| P2860 | cites work | Issues in using progression-free survival when evaluating oncology products | Q37231532 |
| | Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care. | Q37234005 |
| | Cancer screening: the clash of science and intuition | Q37273780 |
| | Proteomics: new technologies and clinical applications | Q37314806 |
| | A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment | Q37411548 |
| | Glycomics and disease markers | Q37457130 |
| | Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial | Q37622656 |
| | Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. | Q52929104 |
| | Women’s perception of the benefits of mammography screening: population-based survey in four countries | Q56535638 |
| | The prospects of glycan biomarkers for the diagnosis of diseases | Q82964007 |
| | The capsule and colorectal-cancer screening--the crux of the matter | Q84236913 |
| | A global view of cancer-specific transcript variants by subtractive transcriptome-wide analysis | Q21092137 |
| | Biomarkers and surrogate endpoints: preferred definitions and conceptual framework | Q28203935 |
| | Rethinking screening for breast cancer and prostate cancer | Q28261959 |
| | Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers | Q28474977 |
| | Emerging technologies for assessing HER2 amplification | Q34659152 |
| | Pharmacogenomics: challenges and opportunities | Q36658763 |
| | American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer | Q36678853 |
| | How close is the bench to the bedside? Metabolic profiling in cancer research | Q37118287 |
| P433 | issue | 7 Suppl 1 | |
| P921 | main subject | biomarker | Q864574 |
| | personalized medicine | Q2072214 |
| P304 | page(s) | 3-10 | |
| P577 | publication date | 2011-07-01 | |
| P1433 | published in | P & T: journal for formulary management | Q15767306 |
| P1476 | title | Personalized medicine: identifying the appropriate patient through biomarkers in oncology | |
| P478 | volume | 36 | |